drugset / Trial / NCT02011451
Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
Phase 2
Withdrawn
Louisiana State University Health Sciences Center in New Orleans
National Multiple Sclerosis Society · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The hypothesis is that 95% pure EGCG can protect brain cells in patients with Multiple Sclerosis. To test this hypothesis we are going to compare the changes in n-Acetyl-Aspartate (a chemical that reflects the number of neurons and their metabolism) over one six between people with MS treated with EGCG at a dose of 400mg twice a day and people with MS treated with a matching sugar pill.
Timeline
- Start
- 2015-12
- Primary completion
- 2017-03
- Completion
- 2017-12
Outcome
Outcome not reported
Stopped (Enrollment): “unable to enroll”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epigallo-catechin-galleate | Unknown | 200 mg | — |